Clinical Trials Directory

Trials / Completed

CompletedNCT03171467

Salpingectomy at the Time of Elective Laparoscopic Cholecystectomy (SaLCHE)

Salpingectomy in Women Undergoing Elective Laparoscopic Cholecystectomy (SaLCHE): A Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

Prophylactic salpingectomy (also called opportunistic, risk-reducing or incidental salpingectomy) has been advocated at the time of gynecologic surgery to reduce the risk of serous ovarian cancer. This study explores the acceptability and feasibility of opportunistic salpingectomy at the time of elective laparoscopic cholecystectomy (LCHE).

Detailed description

Many serous ovarian cancers are now thought to originate in the fimbria of the fallopian tubes. This has led a number of professional societies worldwide to recommend consideration of prophylactic salpingectomy at the time of elective gynecologic surgery or tubal sterilization. This study explores the acceptability and feasibility of incidental (opportunistic, risk-reducing, prophylactic) salpingectomy at the time of a common nongynecologic procedure in women, i.e. elective laparoscopic cholecystectomy (LCHE). The study addresses whether women ≥45 years would accept opportunistic salpingectomy and the technical feasibility (time, port placement, complications) in women who consented to salpingectomy.

Conditions

Interventions

TypeNameDescription
PROCEDURESalpingectomy

Timeline

Start date
2016-08-01
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2017-05-31
Last updated
2018-04-17

Locations

6 sites across 1 country: Austria

Source: ClinicalTrials.gov record NCT03171467. Inclusion in this directory is not an endorsement.